FLIPI and FLIPI-2
Risk factors . | Risk group . | No. of factors . | Outcome, % . | |
---|---|---|---|---|
5-y OS | 10-y OS | |||
FLIPI | Low | 0-1 | 91 | 71 |
Age ≥60 y | ||||
Stage III/IV | Intermediate | 2 | 78 | 51 |
Hemoglobin <12 g/dL | ||||
LDH elevated | High | 3-5 | 53 | 36 |
>4 nodal sites | ||||
3-y PFS | 5-y PFS | |||
FLIPI-2 | Low | 0 | 91 | 80 |
Age ≥60 y | ||||
B2M elevated | Intermediate | 1-2 | 69 | 51 |
Hemoglobin < 2 g/dL | ||||
BM involvement | High | 3-5 | 51 | 19 |
Lymph node diameter >6 cm |
Risk factors . | Risk group . | No. of factors . | Outcome, % . | |
---|---|---|---|---|
5-y OS | 10-y OS | |||
FLIPI | Low | 0-1 | 91 | 71 |
Age ≥60 y | ||||
Stage III/IV | Intermediate | 2 | 78 | 51 |
Hemoglobin <12 g/dL | ||||
LDH elevated | High | 3-5 | 53 | 36 |
>4 nodal sites | ||||
3-y PFS | 5-y PFS | |||
FLIPI-2 | Low | 0 | 91 | 80 |
Age ≥60 y | ||||
B2M elevated | Intermediate | 1-2 | 69 | 51 |
Hemoglobin < 2 g/dL | ||||
BM involvement | High | 3-5 | 51 | 19 |
Lymph node diameter >6 cm |